Since 1980, assisted reproductive technologies (ARTs) such as In-vitro fertilization(IVF) and embryo cryopreservation became popular infertile treatment in the USA and Europe and gradually spread these techniques throughout the globe.
With the passing of time, innovations are added to the techniques and started egg donation, gestational surrogacy, egg freezing, and pre-implantation genetic diagnosis.
The advancement of reproductive technology brings uterus transplantation for women who have damaged or absent uterus.
In 2013, the first birth from a uterus transplant was made possible by A Swedish team in Gothenburg.
The success of this program followed the other three successful births.
This advancement gives the indication that active pregnancy can be transferred to another woman, though no journal published clinical case study mentioned it yet.
But if it is possible, then it will definitely come under surrogacy policy.
The ethical, legal, and social aspects of this process are a considerable factor as it causes the tenderloin of conventional notions of motherhood and family, along with instrumentalizing increases the physiological risk of the donor.
However, uterine transplantation is a way out of the surrogacy dilemma for women with uterine factor infertility.
But in the case of transferring active pregnancy to another woman to gestate, then it again creates a split between the genetic and gestational mother.
Thus, it is a part of gestational surrogacy.
In this case, the donor is not gestating, but another woman rears the child of the donor due to physical or psychological disorder of the donor.
Currently, the active pregnancy transfer needs a thorough assessment of the risk, benefits, and burden of the process by performing further clinical trials.
Informed consenting and counseling for recipient and donor are of utmost need before starting the process.
Embryo transfer is another option to treat infertile women.
In this process, blood type, Rh, and hair and eye color are matched between donor and recipient couples.
Medical assessment detects the readiness for ovulation.
Then male partner’s sperms are inseminated for fertilization of eggs and generated embryo transferred to the intended mother’s womb.
Ravi sharma is a self-motivated, successful entrepreneur and has a solid experience in the fertility segment. and he is the director at ARTbaby Global (ARThealthcare). He is a pharmacy graduate with post-graduation in business administration and has 14 years of rich experience in the field of infertility segment. He loves to write about IVF, Surrogacy and other ART (assisted reproductive technology) news, issues, and updates. He is a Pharmacy graduate (B. Pharm) and M.B.A (marketing).
His most recent success includes the successful launch of the medical tourism company, ARTbaby, which offers treatment options for infertility, egg donation and surrogacy. He likes spending time with his family and writing about various aspects of IVF surrogacy and donating eggs.